DK2260757T3 - System, værktøjer, apparater og et program til diabetesbehandling - Google Patents

System, værktøjer, apparater og et program til diabetesbehandling Download PDF

Info

Publication number
DK2260757T3
DK2260757T3 DK10011427.1T DK10011427T DK2260757T3 DK 2260757 T3 DK2260757 T3 DK 2260757T3 DK 10011427 T DK10011427 T DK 10011427T DK 2260757 T3 DK2260757 T3 DK 2260757T3
Authority
DK
Denmark
Prior art keywords
measurement
glucose
error
blood glucose
insulin
Prior art date
Application number
DK10011427.1T
Other languages
English (en)
Inventor
Matthias Essenpreis
Michael Schoemaker
Bastide Sebastiaan La
Derek Brandt
Sascha Heckermann
Theodor Koschinsky
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK2260757T3 publication Critical patent/DK2260757T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/7445—Display arrangements, e.g. multiple display units
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (12)

1. Medicinsk apparat til diabetesbehandling, især et blodglucosemåleapparat eller en kontinuerligt virkende glucosemonitor eller en insulinpumpe, hvor appa-ratet er indrettet til på basis af i det mindste et resultat af en analyse af en gluco-semåling, hvor målingen har en procentvis målefejl, i det mindste et resultat eller et råd, og hvorved resultatet eller rådet gives afhængigt af den procentvise målefejl, hvorved, til en måling i et første måleinterval eller i flere første måleintervaller, apparatet er indrettet til at vise resultater eller råd til trods for at målingen har en procentvis målefejl, og kendetegnet ved, at, til en måling i et sekundært måleinterval eller i flere sekundære måleintervaller, idet målingen har samme procentvise målefejl, er apparatet indrettet til at forhindre visningen af resultater eller råd.
2. Apparat ifølge krav 1, omfattende et display på apparatet eller separat i forhold hertil, og som er ledningsforbundet eller trådløst forbundet med apparatet.
3. Apparat ifølge krav 1 eller 2, omfattende i det mindste en bevægelsessensor, hvorved displayet kan aktiveres eller undertrykkes afhængig af et signal fra bevægelsessensoren.
4. Apparat ifølge et af kravene 1 til 3, og som har inkorporeret et system til bestemmelse af postprandial glucosekoncentration under betragtning af -præprandial glucosekoncentrationmåling ved selvovervågning af glucose, - virkning af carbohydrat-portion på maksimal glucoseforøgelse, - estimat af carbohydratmængde i måltid, - virkningen af middagsinsulin (prændial insulin) på maksimal glucosefald. - insulindosis, hvorved en fejlmargin til selvovervåget præprandial glucose tages i betragtning og postprandial glucoseværdier beregnes baseret på et terapeutisk aktionsskema.
5. Apparat ifølge krav 4, hvorved en fejl tages i betragtning ved det nævnte system i et eller flere af følgende tilfælde - virkningen af carbohydrat-portion på maksimal glucosekoncentrations-vækst, - estimat af carbohydratmængde i måltid, - virkningen af måltidsinsulin på maksimal glucosekoncentrationsfald, - insulindosis.
6. Apparat ifølge krav 4 eller 5, hvorved postprandial glucosekoncentration bestemmes for forskellige intervaller af præprandial glucosekoncentrationsværdier i overensstemmelse med det terapeutiske skema.
7. Apparat ifølge et af kravene 4 til 6, hvorved resultatet vises som postprandial blodglucose over præprandial blodglucose.
8. Apparat ifølge et af kravene 5 til 7, hvorved det bestemmes, hvorvidt der er nået et kritisk punkt ved at overskride en nedre grænse for glucosekoncentration eller ved overskridelse af en øvre grænse for glucosekoncentration.
9. Apparat ifølge et af kravene 5 til 8, hvorved det terapeutiske skema omfatter en carbohydrat-selvindstilling i forhold til præprandial glucosekoncentration ifølge forbindelsen:
hvorved X er lig med andele af carbohydratportioner (X = 1, 2, 3, 4 eller 5) for blodglucoseintervallet 61 -120 mg/dl.
10. Apparat ifølge et af kravene 1 til 6, hvorved det terapeutiske skema omfatter en præprandial insulindosis-selvindstilling ifølge forholdet:
hvor Y er lig f.eks. 1 enhed insulin per CARB-P for blodglucoseintervallet 81-120 mg/dl.
11. Apparat ifølge krav 5 til 9, hvorved en kontinuerlig blodglucoseovervågning betragtes som følgende:
og hvorved trendene bestemmes som følgende:
12. Fremgangsmåde til driften af et apparat bestående af enten et blodglucose-apparat eller en kontinuerligt virkende glucosemonitor eller en insulinpumpe, hvorved der på basis af i det mindste et resultat af en analyse af en glucosemå-ling, hvor målingen har en procentvis målefejl, gives i det mindste et resultat eller et råd, og hvorved resultatet eller rådet gives afhængigt af den procentvise målefejl, hvorved, til en måling i et første måleinterval eller i flere første måleintervaller, apparatet er indrettet til at vise resultater eller råd til trods for at målingen har en procentvis målefejl, og kendetegnet ved, at, til en måling i et sekundært måleinterval eller i flere sekundære måleintervaller, idet målingen har samme procentvise målefejl, er apparatet indrettet til at forhindre visningen af resultater eller råd.
DK10011427.1T 2005-09-09 2006-09-08 System, værktøjer, apparater og et program til diabetesbehandling DK2260757T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH14682005 2005-09-09
EP06775176A EP1921978B1 (en) 2005-09-09 2006-09-08 Device and program for diabetes care

Publications (1)

Publication Number Publication Date
DK2260757T3 true DK2260757T3 (da) 2016-06-27

Family

ID=37836183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10011427.1T DK2260757T3 (da) 2005-09-09 2006-09-08 System, værktøjer, apparater og et program til diabetesbehandling

Country Status (9)

Country Link
US (2) US7766831B2 (da)
EP (2) EP1921978B1 (da)
JP (1) JP2009506852A (da)
CN (1) CN101257840B (da)
CA (1) CA2621556A1 (da)
DK (1) DK2260757T3 (da)
ES (1) ES2575660T3 (da)
HK (1) HK1124502A1 (da)
WO (1) WO2007028271A2 (da)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
CA2556331A1 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US7654956B2 (en) 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
CN102440785A (zh) 2005-08-31 2012-05-09 弗吉尼亚大学专利基金委员会 传感器信号处理方法及传感器信号处理装置
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7981034B2 (en) 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8206296B2 (en) 2006-08-07 2012-06-26 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US8135548B2 (en) 2006-10-26 2012-03-13 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
WO2008130896A1 (en) 2007-04-14 2008-10-30 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
ES2784736T3 (es) 2007-04-14 2020-09-30 Abbott Diabetes Care Inc Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
CA2683962C (en) 2007-04-14 2017-06-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
ES2817503T3 (es) 2007-04-14 2021-04-07 Abbott Diabetes Care Inc Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
AU2008265541B2 (en) 2007-06-21 2014-07-17 Abbott Diabetes Care, Inc. Health management devices and methods
WO2008157821A1 (en) 2007-06-21 2008-12-24 Abbott Diabetes Care, Inc. Health monitor
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
WO2009105709A1 (en) 2008-02-21 2009-08-27 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US10624577B2 (en) 2008-04-04 2020-04-21 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
WO2010009172A1 (en) 2008-07-14 2010-01-21 Abbott Diabetes Care Inc. Closed loop control system interface and methods
MX2011002235A (es) * 2008-08-29 2011-04-05 Fio Corp Dispositivo de prueba de diagnostico portatil de un solo uso, y un sistema y metodo asociado para probar muestras de prueba biologicas y ambientales.
US20100057040A1 (en) 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US9149220B2 (en) 2011-04-15 2015-10-06 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
WO2010121084A1 (en) 2009-04-15 2010-10-21 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
EP2419015A4 (en) * 2009-04-16 2014-08-20 Abbott Diabetes Care Inc ANALYTE SENSOR CALIBRATION MANAGEMENT
EP2425209A4 (en) 2009-04-29 2013-01-09 Abbott Diabetes Care Inc METHOD AND SYSTEM FOR REAL-TIME CALIBRATION OF AN ANALYTICAL SENSOR WITH RETROACTIVE FILLING
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US20100324932A1 (en) * 2009-06-19 2010-12-23 Roche Diagnostics Operations, Inc. Methods and systems for advising people with diabetes
RU2553387C2 (ru) 2009-06-30 2015-06-10 Лайфскен, Инк. Способы определения концентрации аналита и устройство для расчета терапевтической дозы базального инсулина
EP3689237B1 (en) 2009-07-23 2021-05-19 Abbott Diabetes Care, Inc. Method of manufacturing and system for continuous analyte measurement
EP3173014B1 (en) 2009-07-23 2021-08-18 Abbott Diabetes Care, Inc. Real time management of data relating to physiological control of glucose levels
WO2011014704A2 (en) 2009-07-30 2011-02-03 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
WO2011026053A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Displays for a medical device
AU2010286917B2 (en) 2009-08-31 2016-03-10 Abbott Diabetes Care Inc. Medical devices and methods
JP5503234B2 (ja) * 2009-09-18 2014-05-28 シスメックス株式会社 食後血糖推定装置、食後血糖推定方法及びコンピュータプログラム
CA3077994C (en) 2009-09-29 2022-06-21 Lifescan Scotland Limited Analyte testing method and device for diabetes management
EP2482720A4 (en) 2009-09-29 2014-04-23 Abbott Diabetes Care Inc METHOD AND APPARATUS FOR PROVIDING NOTIFICATION FUNCTION IN SUBSTANCE MONITORING SYSTEMS
US8185181B2 (en) 2009-10-30 2012-05-22 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
ES2532146T3 (es) 2010-02-25 2015-03-24 Lifescan Scotland Limited Procedimiento y sistema de prueba de analitos con notificación de tendencias de glucemia alta y baja
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US9618517B2 (en) * 2010-09-28 2017-04-11 Lifescan Scotland Limited Analyte measurement method and system with error trapping
AU2012254094B2 (en) 2011-02-28 2016-08-25 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
EP2762076A4 (en) * 2011-09-27 2015-05-27 Terumo Corp ANALYTÜBERWACHUNGSSYSTEM
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
WO2013066873A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
WO2014052136A1 (en) 2012-09-26 2014-04-03 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US10201656B2 (en) 2013-03-13 2019-02-12 Tandem Diabetes Care, Inc. Simplified insulin pump for type II diabetics
US10573413B2 (en) * 2013-03-14 2020-02-25 Roche Diabetes Care, Inc. Method for the detection and handling of hypoglycemia
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9492608B2 (en) 2013-03-15 2016-11-15 Tandem Diabetes Care, Inc. Method and device utilizing insulin delivery protocols
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
WO2014152034A1 (en) 2013-03-15 2014-09-25 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
CA2933166C (en) 2013-12-31 2020-10-27 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
EP3865063A1 (en) 2014-03-30 2021-08-18 Abbott Diabetes Care, Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
CN105528748A (zh) * 2015-06-16 2016-04-27 江苏德尔福医疗器械有限公司 血糖实时监测管理及治疗系统
WO2017011346A1 (en) 2015-07-10 2017-01-19 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US10311976B2 (en) * 2016-04-28 2019-06-04 Roche Diabetes Care, Inc. Bolus calculator with probabilistic carbohydrate measurements
EP3600014A4 (en) 2017-03-21 2020-10-21 Abbott Diabetes Care Inc. METHODS, DEVICES AND SYSTEM FOR PROVIDING DIAGNOSIS AND THERAPY FOR DIABETIC CONDITION
CN107137093B (zh) * 2017-04-20 2019-06-07 浙江大学 一种包含异常血糖概率报警器的连续血糖监测设备
CA3059985C (en) 2017-05-05 2023-08-08 Eli Lilly And Company Closed loop control of physiological glucose
EP3928687B1 (en) 2017-10-24 2024-06-26 Dexcom, Inc. Wearable device with pre-connected analyte sensor
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
AU2018388898A1 (en) 2017-12-21 2020-06-11 Ypsomed Ag Closed loop control of physiological glucose
AU2019288473A1 (en) 2018-06-22 2020-12-10 Ypsomed Ag Insulin and pramlintide delivery systems, methods, and devices
CN115804593A (zh) * 2021-09-15 2023-03-17 深圳硅基仿生科技股份有限公司 针对用餐前后的葡萄糖浓度水平的葡萄糖监测系统
CN115804595A (zh) * 2021-09-15 2023-03-17 深圳硅基仿生科技股份有限公司 针对睡眠前后的葡萄糖浓度水平的葡萄糖监测系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH146805A (de) 1929-07-24 1931-05-15 Koenig Wenzel Badebrause.
US3939640A (en) * 1974-12-12 1976-02-24 Kahn Leonard R System for illuminating the display of a wrist watch
US5791344A (en) * 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
JPH1156822A (ja) * 1997-08-19 1999-03-02 Omron Corp 血糖測定装置
US6233471B1 (en) * 1998-05-13 2001-05-15 Cygnus, Inc. Signal processing for measurement of physiological analysis
US6925393B1 (en) * 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
JP2001212114A (ja) * 2000-02-02 2001-08-07 Matsushita Electric Ind Co Ltd 血糖計
JP3298008B2 (ja) * 2000-02-09 2002-07-02 オムロン株式会社 糖代謝能力判定装置
AU5096801A (en) * 2000-03-31 2001-10-15 Lifescan Inc Electrically-conductive patterns for monitoring the filling of medical devices
US20020019707A1 (en) * 2000-06-26 2002-02-14 Cohen Alan M. Glucose metering system
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US20030108976A1 (en) * 2001-10-09 2003-06-12 Braig James R. Method and apparatus for improving clinical accuracy of analyte measurements
WO2004023972A2 (en) * 2002-09-11 2004-03-25 Becton, Dickinson And Company Monitoring blood glucose including convenient display of measurement values ________________________________________________________
US7778680B2 (en) * 2003-08-01 2010-08-17 Dexcom, Inc. System and methods for processing analyte sensor data
DK1678490T3 (da) * 2003-10-31 2009-10-05 Lifescan Scotland Ltd Fremgangsmåde til reduktion af interferenser i en elektrokemisk sensor ved anvendelse af to forskellige påförte potentialer
US7654956B2 (en) * 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
US7254516B2 (en) * 2004-12-17 2007-08-07 Nike, Inc. Multi-sensor monitoring of athletic performance

Also Published As

Publication number Publication date
ES2575660T3 (es) 2016-06-30
US20080242963A1 (en) 2008-10-02
EP2260757A1 (en) 2010-12-15
WO2007028271A3 (en) 2007-06-07
US20100235316A1 (en) 2010-09-16
CN101257840A (zh) 2008-09-03
US10299737B2 (en) 2019-05-28
CN101257840B (zh) 2013-04-24
EP1921978B1 (en) 2012-08-01
EP2260757B1 (en) 2016-03-16
WO2007028271A2 (en) 2007-03-15
WO2007028271A8 (en) 2012-04-26
US7766831B2 (en) 2010-08-03
HK1124502A1 (en) 2009-07-17
CA2621556A1 (en) 2007-03-15
JP2009506852A (ja) 2009-02-19
EP1921978A2 (en) 2008-05-21

Similar Documents

Publication Publication Date Title
DK2260757T3 (da) System, værktøjer, apparater og et program til diabetesbehandling
AU2022200642B2 (en) Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US20210361867A1 (en) Integrated closed-loop medication delivery with error model and safety check
US20210100515A1 (en) Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US9990581B2 (en) Insulin dosage assessment and recommendation system
JP2007014751A (ja) インスリン投与量調節のために糖尿病患者の体液について一連のグルコース濃度を評価する方法と装置
US20040197846A1 (en) Determination of glucose sensitivity and a method to manipulate blood glucose concentration
US20100030483A1 (en) Assessment method to process a glucose concentration signal and devices thereof
US20120271560A1 (en) Asthma Status Scoring Method and System With Confidence Ratings
Fiore et al. Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?
JP6316299B2 (ja) 患者の健康状態の評価のためのシステム及び方法
Schäfer et al. Good reproducibility of heart rate variability after orthostatic challenge in patients with a history of acute coronary syndrome
Dosani et al. Clinical evaluation of algorithms for context-sensitive physiological monitoring in children
Vigersky et al. The Myth of MARD (M ean A bsolute R elative D ifference): Limitations of MARD in the Clinical Assessment of Continuous Glucose Monitoring Data
Hayter et al. Performance standards for continuous glucose monitors
Sheffield et al. Accuracy and precision of four value-added blood glucose meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure Pro
MacFarlane Blood glucose monitor accuracy: why it is so important.
Brake Long-term effects of continuous glucose monitoring on HbA